Trial Profile
A Phase 1, Randomized, Double-Blind, Placebo Controlled, Multi-Dose Study to Determine the Safety, Tolerance and Pharmacokinetics of 3 Dose Levels of Larazotide Acetate (AT-1001) in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Jul 2020
Price :
$35
*
At a glance
- Drugs Larazotide (Primary)
- Indications Coeliac disease; Crohn's disease; Irritable bowel syndrome; Type 1 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Alba Therapeutics
- 17 Dec 2006 New trial record.